ATLANTA, October 1, 2017 / -Commenda Capital, LLC, an Atlanta based merchant banking firm, has completed a Junior Secured financing -for Nanovis, LLC. Commenda Capital acted as financial advisor and was a co-investor in this financing. Nanovis will use the proceeds of this financing for working capital purposes supporting growth in the sales and marketing operations of the firm.A combination of new and existing investors participated in the financing.
Nanovis, LLC is a medical device company based in Columbia City, Indiana that is committed to developing spinal implant systems that can reduce fixation and infection related complications.The Company’s patented and proprietary regenerative technology platforms provide clearly differentiated surface advantages enabling its medical devices to achieve improved outcomes. Focused on aggressive, sustainable growth across multiple markets, Nanovis is commercializing science-driven platforms in: 1) the deeply porous scaffold currently available with the FortiCore® line of spinal interbody fusion devices; 2) a developmental nanosurface technology; and 3) developmental technology with anti-colonization and anti-microbial capabilities. Inquiries about licensing nanotechnology enhanced implant surfaces are welcomed by Matt Hedrick, Nanovis’ CEO at email@example.com.
For additional informationplease visitwww.nanovisinc.comor call 1-877-907-NANO (6266).
Commenda Capital, LLC is a merchant banking firm, headquartered in Atlanta, which supports lower and middle-market companies seeking capital for growth, recapitalization, shareholder liquidity, and restructuring. Commenda supports its clients with services that go beyond capital including targeted marketing plans, strategic planning, and operational resources making the client’s unique and compelling value proposition obvious to all stakeholders. Commenda calls this Capital+. It’s the “+” that makes all the difference.
For additional information please visit www.commendacapital.com or contact: John Runningen, Commenda Capital, LLC, 770-858-0085